Cetera Investment Advisers’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $234K | Buy |
11,415
+554
| +5% | +$11.4K | ﹤0.01% | 3602 |
|
|
2025
Q1 | $223K | Sell |
10,861
-500
| -4% | -$10.2K | ﹤0.01% | 3522 |
|
|
2024
Q4 | $257K | Sell |
11,361
-114
| -1% | -$2.58K | ﹤0.01% | 3229 |
|
|
2024
Q3 | $282K | Sell |
11,475
-759
| -6% | -$18.7K | ﹤0.01% | 3118 |
|
|
2024
Q2 | $283K | Sell |
12,234
-1,100
| -8% | -$25.4K | ﹤0.01% | 3081 |
|
|
2024
Q1 | $321K | Buy |
+13,334
| New | +$321K | ﹤0.01% | 2971 |
|
|
2021
Q2 | – | Sell |
-5,412
| Closed | -$247K | – | 1785 |
|
|
2021
Q1 | $247K | Sell |
5,412
-285
| -5% | -$13K | ﹤0.01% | 1350 |
|
|
2020
Q4 | $262K | Buy |
+5,697
| New | +$262K | 0.01% | 1312 |
|